N4 Pharma's market cap is currently £9.52M. The company's EPS TTM is p-0.001; its P/E ratio is ―; N4 Pharma is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
